Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Guohui Zang"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background The level of tumor abnormal protein (TAP) level has a significant impact on tumor growth, recurrence, and metastasis. Previous studies have highlighted the influence of the mutations in exons 19 and 21 of the epidermal growth fact
Externí odkaz:
https://doaj.org/article/a0e99f30a6074e2681355435be5cbf69
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Background: Esophageal squamous cell carcinoma (ESCC) acts as a fatal malignant tumor among human beings and is marked by late-stage diagnosis, frequent recurrence, metastasis, and therapy resistance. Tumor abnormal protein (TAP) remarkably affects c
Externí odkaz:
https://doaj.org/article/e5169e3b12aa4fe399b0ed94fe0e5325
Publikováno v:
Aging.
Lung adenocarcinoma (LUAD) remains a major reason of cancer-associated mortality globally, and there exists a lack of indicators for survival in LUAD patients. Therefore, it is clinically required to obtain a novel prognostically indicator for guidin
To identify a cancer stemness-related prognostic signature, we analyzed RNA-seq data of patients with lung adenocarcinoma from the TCGA and GEO cohort using univariate Cox and LASSO analysis. Eight genes (PLEK2, GPX8, TCN1, PERP, CD79A, PAX5, FSCN1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e836d057af8263b58857ce13e4168271
https://doi.org/10.21203/rs.3.rs-1442582/v1
https://doi.org/10.21203/rs.3.rs-1442582/v1
Autor:
Yongbing Chen, Hanqing Wu, Jie Yao, Wenguang Zhang, Yuanjun Cheng, Liu Yu, Guohui Zang, Pinghai He, Youming Zhang, Bin Chen, Haibing Wang
Publikováno v:
Cancer Management and Research. 12:1941-1946
Background The most common cancer among humans is lung cancer. Non-small cell lung cancer (NSCLC) comprises the majority of these cases. In the development and progression of cancers across the spectrum, tumor abnormal protein (TAP) plays crucial rol
Publikováno v:
Frontiers in Surgery
Frontiers in Surgery, Vol 8 (2021)
Frontiers in Surgery, Vol 8 (2021)
Background: Esophageal squamous cell carcinoma (ESCC) acts as a fatal malignant tumor among human beings and is marked by late-stage diagnosis, frequent recurrence, metastasis, and therapy resistance. Tumor abnormal protein (TAP) remarkably affects c